Public health, in this first phase of limited availability of vaccines, but still worrying rates of contagion and sustained transmission of the virus, will concentrate resources with the aim of reducing serious cases and deaths and maintaining critical essential services. as highlighted in the Strategic Plan for anti-SARS-CoV-2 / COVID-19 vaccination - prepared by the Ministry of Health, Extraordinary Commissioner for Emergency, Istituto Superiore di Sanità (ISS), National Agency for Regional Health Services (AGENAS ) and the Italian Medicines Agency (AIFA). For the national vaccination plan, almost 20,000 doctors, nurses, health assistants, social health workers and administrative staff have been employed.
Who makes the vaccine
To date, the European Commission has signed agreements with 6 pharmaceutical companies (although the number of companies that will produce the vaccine is expected to grow) for over 1.3 billion guaranteed doses of authorized vaccines, which rise to almost 2 billion if you count. optional purchases. The six companies are: CureVac, AstraZeneca, Johnson & Johnson, Pfizer / BioNTech (the vaccines arrived in Italy were formulated by Pfitzer), Sanofi-GSK, and Moderna, the so-called "Italian vaccine". The Commission is also negotiating with Novavax for the purchase of another 200 million doses. To date, the doses are distributed to the Member States guaranteeing equity, based on the population. To avoid waste, Aifa has ordered the use of 6 doses and not 5 from each single bottle of vaccine.
provides that vaccination is free and guaranteed to all, by voluntary membership. They have been identified, and partially already vaccinated, belonging to the categories with priority in the initial phase, when the availability of vaccines is still limited. In the plan, the governance of which is coordinated by the Minister of Health, the structure of the Extraordinary Commissioner for Emergency, the Regions and Autonomous Provinces, all aspects of intervention are defined: strategy, staff training, logistics, communication, surveillance and models of impact and economic evaluation.
The Strategic Plan may be subject to modifications and changes in the course of work, depending on the evolution of vaccination efficacy and / or immunogenicity in different age groups and risk groups; on the safety of vaccination in different age groups and groups at risk; the effect of the vaccine on infection, transmission or protection from serious forms of pathology. Some essential and crucial variables will be taken into consideration: the dynamics of transmission of the SARS-CoV-2 virus in the population; epidemiological characteristics, microbiological and clinical conditions of Covid-19.
:- Doctors, nurses, health and social health workers. Health and social health personnel have a higher risk of being exposed to Covid-19 infection and passing it on to patients. Vaccination of frontline professionals also helps to maintain the full efficiency of the health service.
- Residents and staff of residential aged care facilities. The guests of the nursing homes (RSA), already heavily affected by the pandemic, are at high risk of serious illness due to their advanced age, the presence of multiple previous diseases and the need for daily assistance. Therefore, both the resident population and RSA personnel should be considered high priority in the initial phase.
- Elderly people (over 80 years old). An age-based vaccination schedule allows for increased coverage in people with various risk factors, as the prevalence of comorbidities increases with age.
During the epidemic, and with the careful monitoring of the evolution of the contagion, it will be possible to implement adaptive strategies, if particular risk categories or sensitive population groups are identified, as well as vaccine stocks with "reactive" strategies (reactive vaccination), should significant outbreaks develop in specific areas of Italy.
Further information and updates on 2019-nCov
For more detailed information on the new Coronavirus, on correct prevention, on infections in Italy, on the rules to be respected and on the quarantine procedures, we recommend reading the dedicated articles:
- Coronavirus 2019-nCoV: How to Recognize the First Symptoms and What to Do
- New Coronavirus: Rules to Follow
- Coronavirus: how to prevent the risk of contagion from 2019 nCoV
- New Coronavirus vaccine: updates
- Coronavirus: prevention and updates on the 2019 nCoV infection in Italy
- Coronavirus and SARS: similarities and differences on infection and transmission of the virus
- Maskne or Acne da Mask: What is it? Why does it manifest itself?
- Templates: Comparative Types, Functions and Methods of Use
- Physical Activity and Masks
